v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ASSOCIATION OF HYPOMAGNESEMIA AND DIABETIC NEPHROPATHY

AUTHORS:

Dr Nehan Shakeel, Dr Fatima Jabbar, Dr Iqra Raees

ABSTRACT:

Background: Hypomagnesaemia is a regular sequel of type II diabetes mellitus. Objective: This research has aimed to highlight the association of hypomagnesemia in type II diabetes in order to identify and treat the electrolyte disorder to prevent complications setting in early, to approximate the prevalence of Hypomagnesemia \ with Diabetic nephropathy and to find association between both in order to correct reduced serum magnesium levels at an early stage for prevention and progression of complications. Method: the study was conducted in settings of Faisalabad Medical University, Faisalabad with Duration of Study of 06 months after the approval of synopsis. Using a Sample Size of 86 patients calculated Using WHO sample size calculator with the Level of confidence (%) = 95% . anticipated Population Proportion = 17%. Data was collected from Faisalabad Medical University, Faisalabad outdoor nephrology and medicine department with the approval of ethical review committee of Combined Military Hospital Lahore after seeking written informed consent from the patients through a Survey proforma.it was a cross sectional study with chi- square test applied in order to find association between reduced serum magnesium levels and diabetic nephropathy. Results:there was 100% prevalence of Hypomagnesemia patients with End Stage Renal Disease with majority in age group in 55 to 65yrs of age independent of gender.Association was found to be significant p<0.005 Conclusion: hypomagnesemia is assoiated with diabetic nehropathy that ultimately leads to renal failure. Keywords:End stage renal disease,Hypomagnesemia,diabetes mellits type II.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.